Wellgistics Health completes reverse stock split
Analysis based on 9 articles · First reported May 20, 2026 · Last updated May 26, 2026
The reverse stock split by Wellgistics is intended to increase its share price to meet Nasdaq-100 listing requirements, potentially preventing delisting and stabilizing investor confidence. However, the underlying reasons for the low stock price, such as poor performance, may still concern investors, leading to continued volatility for Wellgistics's stock.
Wellgistics, a Health IT company, completed a 1-for-50 reverse stock split of its common stock, effective May 26, 2026. This action, approved by stockholders on April 2, 2026, aims to increase the per share trading price to regain compliance with The Nasdaq-100 Capital Market's minimum bid price requirement. The split reduced outstanding shares from approximately 125.7 million to 2.5 million. No fractional shares were issued, with rounding up to the nearest whole share. The company's stock had been trading at $0.13, down 95% over the past year. Wellgistics is also exploring strategic opportunities, including potential acquisitions of WellCare Today and MiNK Therapeutics, and has formed a joint venture with KareRx Hub.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard